Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine BreakthroughZacks Investment Research • 09/01/26
Moderna Stock More Than Doubled in August. Is the Stock a Buy, a Hold, or a Sell?The Motley Fool • 09/01/26
22 best-performing stocks of August, as the software industry continues its recoveryMarket Watch • 08/31/26
BioNTech Tumbles 8% as Colorectal Cancer Vaccine Trial Fails, Moderna Drops 6%, Pfizer Holds Flat24/7 Wall Street • 08/28/26
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior NotesAccesswire • 08/28/26
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthroughReuters • 08/28/26
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior NotesAccesswire • 08/27/26
Explainer: How the Merck/Moderna cancer vaccine works and possible barriers to wide useReuters • 08/25/26